The GNB3 C825T polymorphism and essential hypertension: A meta-analysis of 34 studies including 14 094 cases and 17 760 controls

Journal of Hypertension

Volumn 25, Issue 3, 2007, Pages 487-500

  Bagos, Pantelis G ^a   Elefsinioti, Antigoni L ^a   Nikolopoulos, Georgios K ^b   Hamodrakas, Stavros J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Hellenic Centre for Disease Control and Prevention   (Greece)

Author keywords

G protein 3; Genetic association; Hypertension; Meta analysis; Random effects

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE DISTRIBUTION; ALLELE; AMINO ACID SEQUENCE; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA ANALYSIS; DIABETES MELLITUS; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART INFARCTION; HUMAN; LATITUDE; META ANALYSIS; OBESITY; PRIORITY JOURNAL; SEX RATIO; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 33846815156     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328011db24     Document Type: Article

References (59)

1. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18:45-48.
2. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, et al. Insights intoGprotein structure, function, and regulation. Endocr Rev 2003; 24:765-781.
3. Elefsinioti AL, Bagos PG, Spyropoulos IC, Hamodrakas SJ. A database for G proteins and their interaction with GPCRs. BMC Bioinformatics 2004; 5:208.
4. Li D, Roberts R. WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases. Cell Mol Life Sci 2001; 58:2085-2097.
5. Rosskopf D, Busch S, Manthey I, Siffert W. G protein beta 3 gene: structure, promoter, and additional polymorphisms. Hypertension 2000; 36:33-41.
6. Rosskopf D, Manthey I, Habich C, Kielbik M, Eisenhardt A, Nikula C, et al. Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J 2003; 371:223-232.
7. Rosskopf D, Kielbik M, Manthey I, Bilmen G, Eisenhardt A, Siffert W. Characterization of the splice variant Gbeta3v of the human G-protein Gbeta3 subunit. Biochim Biophys Acta 2003; 1626:33-42.
8. McAuley L, Pham B, Tugwell P, Moher D. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet 2000; 356:1228-1231.
9. Pan Z, Trikalinos TA, Kavvoura FK, Lau J, Ioannidis JP. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Med 2005; 2:e334.
10. Greenland S. Meta-analysis. In: Rothman KJ, Greenland S, editors. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 1998. pp. 643-673.
11. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012.
12. Petiti DB. Meta-analysis, decision analysis and cost-effectiveness analysis. Oxford: Oxford University Press; 1994.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
15. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999; 18:2693-2708.
16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-1101.
17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
18. Duval S, Tweedie R. A nonparametric 'trim and fill' method of accounting for publication bias in meta-analysis. JASA 2000; 95:89-98.
19. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 2006; 163:300-309.
20. Ioannidis JP, Trikalinos TA. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 2005; 58:543-549.
21. Brand E, Herrmann SM, Nicaud V, Ruidavets JB, Evans A, Arveiler D, et al. The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension. Hypertension 1999; 33:1175-1178.
22. Ishikawa K, Imai Y, Katsuya T, Ohkubo T, Tsuji I, Nagai K, et al. Human G-protein beta3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure. Am J Hypertens 2000; 13:140-145.
23. Hengstenberg C, Schunkert H, Mayer B, Doring A, Lowel H, Hense HW, et al. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001; 49:820-827.
24. Dai SP, Shi JP, Ding Q, Wang HL, Dong LY, Sun D, et al. Polymorphism analysis of 825C/T of the G-protein beta 3 subunit in high risk population of hypertension in the northeast China. Yi Chuan Xue Bao 2002; 29:294-298.
25. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. G protein beta3 subunit variant and essential hypertension in Japanese. Hypertension 1998; 32:935-938.
26. Wang H, Sun N, Gao Y, Gou S. G protein beta 3 subunit C825T polymorphism and essential hypertension in Chinese. Beijing Da Xue Xue Bao 2003; 35:423-425.
27. Dzida G, Golon-Siekierska P, Puzniak A, Sobstyl J, Bilan A, Mosiewicz J, et al. G-protein beta3 subunit gene C825T polymorphism is associated with arterial hypertension in Polish patients with type 2 diabetes mellitus. Med Sci Monit 2002; 8:CR597-CR602.
28. Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, et al. Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia 2006; 49:75-82.
29. Sedlacek K, Fischer M, Erdmann J, Hengstenberg C, Holmer S, Kurzinger S, et al. Relation of the G protein beta3-subunit polymorphism with left ventricle structure and function. Hypertension 2002; 40:162-167.
30. Snapir A, Heinonen P, Tuomainen TP, Lakka TA, Kauhanen J, Salonen JT, et al. G-protein beta3 subunit C825T polymorphism: no association with risk for hypertension and obesity. J Hypertens 2001; 19:2149-2155.
31. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 1998; 32:1094-1097.
32. Suwazono Y, Okubo Y, Kobayashi E, Miura K, Morikawa Y, Ishizaki M, et al. Lack of association of human G-protein beta 3 subunit variant with hypertension in Japanese workers. J Hypertens 2004; 22:493-500.
33. Yamamoto M, Abe M, Jin JJ, Wu Z, Tabara Y, Mogi M, et al. Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese. Biochem Biophys Res Commun 2004; 316:744-748.
34. Zychma MJ, Zukowska-Szczechowska E, Ossowska-Szymkowicz I, Trautsolt W, Grzeszczak W. G-Protein beta(3) subunit C825T variant, nephropathy and hypertension in patients with type 2 (Non-insulin-dependent) diabetes mellitus. Am J Nephrol 2000; 20:305-310.
35. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 2005; 56:17-28.
36. Siffert W. G-protein beta3 subunit 825T allele and hypertension. Curr Hypertens Rep 2003; 5:47-53.
37. Castellano M. Genetic association studies on gender- and age-related phenotypes: the case of GNB3 gene. J Hypertens 2003; 21:683-685.
38. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003; 361:567-571.
39. Conn VS, Valentine JC, Cooper HM, Rantz MJ. Grey literature in metaanalyses. Nurs Res 2003; 52:256-261.
40. Ioannidis JP. Journals should publish all 'null' results and should sparingly publish 'positive' results. Cancer Epidemiol Biomarkers Prev 2006; 15:186.
41. Ioannidis JP. Commentary: Grading the credibility of molecular evidence for complex diseases. Int J Epidemiol 2006; 35:572-578.
42. Young JH, Chang YP, Kim JD, Chretien JP, Klag MJ, Levine MA, et al. Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion. PLoS Genet 2005; 1:e82.
43. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000; 35:1297-1300.
44. Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks. Hypertension 1999; 34:1193-1196.
45. Beige J, Hohenbleicher H, Distler A, Sharma AM. G-Protein beta3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension 1999; 33:1049-1051.
46. Tsai CH, Yeh HI, Chou Y, Liu HF, Yang TY, Wang JC, et al. G protein beta3 subunit variant and essential hypertension in Taiwan - a case-control study. Int J Cardiol 2000; 73:191-195; discussion 197-198.
47. Buchmayer H, Sunder-Plassmann G, Hirschl MM, Kletzmayr J, Woisetschlager C, Laggner AN, et al. G-protein beta3 subunit gene (GNB3) polymorphism 825C→T in patients with hypertensive crisis. Crit Care Med 2000; 28:3203-3206.
48. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21:1559-1573.
49. Kario K, Fujiwara M, Sone Y, Saiki K, Hoshide S, Shimada K, et al.G protein beta3 subunit gene variant, twenty-four-hour blood pressure, and hypertensive cerebrovascular disease in a Japanese population. Am J Hypertens 1999; 12:1159-1160.
50. Tozawa Y. G protein beta3 subunit variant: tendency of increasing susceptibility to hypertension in Japanese. Blood Press 2001; 10:131-134.
51. Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H, Yokota M. Prediction of genetic risk for hypertension. Hypertension 2003; 41:1035-1040.
52. Huang X, Ju Z, Song Y, Zhang H, Sun K, Lu H, et al. Lack of association between the G protein beta3 subunit gene and essential hypertension in Chinese: a case-control and a family-based study. J Mol Med 2003; 81:729-735.
53. Wang X, Wang S, Lin R, Jiang X, Cheng Z, Turdi J, et al. GNB3 gene C825T and ACE gene I/D polymorphisms in essential hypertension in a Kazakh genetic isolate. J Hum Hypertens 2004; 18:663-668.
54. Shioji K, Kokubo Y, Mannami T, Inamoto N, Morisaki H, Mino Y, et al. Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study. Hypertens Res 2004; 27:31-37.
55. Potoczna N, Wertli M, Steffen R, Ricklin T, Lentes KU, Horber FF. G protein polymorphisms do not predict weight loss and improvement of hypertension in severely obese patients. J Gastrointest Surg 2004; 8:862-868; discussion 868.
56. Martin DN, Andreu EP, Ramirez Lorca R, Garcia-Junco PS, Vallejo Maroto I, Santos RA, et al. G-protein beta-3 subunit gene C825 T polymorphism: influence on plasma sodium and potassium concentrations in essential hypertensive patients. Life Sci 2005; 77:2879-2886.
57. Mahmood MS, Mian ZS, Afzal A, Frossard PM. G-protein beta-3 subunit gene 825C>T dimorphism is associated with left ventricular hypertrophy but not essential hypertension. Med Sci Monit 2005; 11:CR6-CR9.
58. Li B, Ge D, Wang Y, Zhao W, Zhou X, Gu D, et al. G protein beta 3 subunit gene variants and essential hypertension in the northern Chinese Han population. Ann Hum Genet 2005; 69:468-473.
59. Kedzierska K, Ciechanowski K, Safranow K, Bober J, Golembiewska E, Kwiatkowska E, et al. GNB3 C825T and ACE I/D polymorphisms on the sodium-proton exchanger and the prevalence of essential hypertension in males. Arch Med Res 2006; 37:150-157.